BACKGROUND: Botulinum toxin type A (BoNT-A) injection has become the most popular cosmetic nonsurgical procedure, and it has been suggested that BoNT-A injections may improve emotional states when frown lines are treated. OBJECTIVES: To evaluate symptoms of depression and self-esteem before and after onabotulinumtoxinA (ONA) injections in the glabella in subjects with and without depression. METHODS: Twenty-five subjects with depression were allocated into one group and 25 subjects without depression were matched to those according to demographic characteristics. The Beck Depression Inventory (BDI) and Rosenberg Self-Esteem Scale (RSES) were used to assess depression symptoms and self-esteem, respectively. Patients were assessed up to 12 weeks after the intervention. RESULTS: Patients with depression had significant improvement in depression symptoms after ONA injections. The maximum effect occurred within the first 8 weeks after treatment. A significant reduction from baseline in BDI score and significant improvement in self-esteem were also observed in patients with depression. CONCLUSION: This research presents new data regarding BoNT-A as a potential treatment to improve depression symptoms in patients with Major Depressive Disorder. Self-esteem scores alone cannot explain the improvement in depression symptoms.
BACKGROUND: Botulinum toxin type A (BoNT-A) injection has become the most popular cosmetic nonsurgical procedure, and it has been suggested that BoNT-A injections may improve emotional states when frown lines are treated. OBJECTIVES: To evaluate symptoms of depression and self-esteem before and after onabotulinumtoxinA (ONA) injections in the glabella in subjects with and without depression. METHODS: Twenty-five subjects with depression were allocated into one group and 25 subjects without depression were matched to those according to demographic characteristics. The Beck Depression Inventory (BDI) and Rosenberg Self-Esteem Scale (RSES) were used to assess depression symptoms and self-esteem, respectively. Patients were assessed up to 12 weeks after the intervention. RESULTS:Patients with depression had significant improvement in depression symptoms after ONA injections. The maximum effect occurred within the first 8 weeks after treatment. A significant reduction from baseline in BDI score and significant improvement in self-esteem were also observed in patients with depression. CONCLUSION: This research presents new data regarding BoNT-A as a potential treatment to improve depression symptoms in patients with Major Depressive Disorder. Self-esteem scores alone cannot explain the improvement in depression symptoms.
Authors: Nicholas A Coles; David S March; Fernando Marmolejo-Ramos; Jeff T Larsen; Nwadiogo C Arinze; Izuchukwu L G Ndukaihe; Megan L Willis; Francesco Foroni; Niv Reggev; Aviv Mokady; Patrick S Forscher; John F Hunter; Gwenaël Kaminski; Elif Yüvrük; Aycan Kapucu; Tamás Nagy; Nandor Hajdu; Julian Tejada; Raquel M K Freitag; Danilo Zambrano; Bidisha Som; Balazs Aczel; Krystian Barzykowski; Sylwia Adamus; Katarzyna Filip; Yuki Yamada; Ayumi Ikeda; Daniel L Eaves; Carmel A Levitan; Sydney Leiweke; Michal Parzuchowski; Natalie Butcher; Gerit Pfuhl; Dana M Basnight-Brown; José A Hinojosa; Pedro R Montoro; Lady G Javela D; Kevin Vezirian; Hans IJzerman; Natalia Trujillo; Sarah D Pressman; Pascal M Gygax; Asil A Özdoğru; Susana Ruiz-Fernandez; Phoebe C Ellsworth; Lowell Gaertner; Fritz Strack; Marco Marozzi; Marco Tullio Liuzza Journal: Nat Hum Behav Date: 2022-10-20
Authors: Simona Guerzoni; Lanfranco Pellesi; Carlo Baraldi; Michela Maria Cainazzo; Andrea Negro; Paolo Martelletti; Luigi Alberto Pini Journal: Front Neurol Date: 2017-11-03 Impact factor: 4.003
Authors: Oreste Affatato; Thiago C Moulin; Claudia Pisanu; Victoria S Babasieva; Marco Russo; Elif I Aydinlar; Paola Torelli; Vladimir N Chubarev; Vadim V Tarasov; Helgi B Schiöth; Jessica Mwinyi Journal: J Transl Med Date: 2021-03-31 Impact factor: 5.531
Authors: M Axel Wollmer; Nadeem Kalak; Stefanie Jung; Claas de Boer; Michelle Magid; Jason S Reichenberg; Serge Brand; Edith Holsboer-Trachsler; Tillmann H C Kruger Journal: Front Psychiatry Date: 2014-03-31 Impact factor: 4.157